Your browser doesn't support javascript.
loading
Foetal alcohol spectrum disorder in Aotearoa, New Zealand: Estimates of prevalence and indications of inequity.
Romeo, Jose S; Huckle, Taisia; Casswell, Sally; Connor, Jennie; Rehm, Jurgen; McGinn, Valerie.
Afiliação
  • Romeo JS; SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand.
  • Huckle T; SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand.
  • Casswell S; SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand.
  • Connor J; Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.
  • Rehm J; Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
  • McGinn V; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Drug Alcohol Rev ; 42(4): 859-867, 2023 05.
Article em En | MEDLINE | ID: mdl-36809679
INTRODUCTION: Foetal alcohol spectrum disorder (FASD) is 100% caused by alcohol. The lifelong disability caused by prenatal alcohol exposure cannot be reversed. Lack of reliable national prevalence estimates of FASD is common internationally and true of Aotearoa, New Zealand. This study modelled the national prevalence of FASD and differences by ethnicity. METHODS: FASD prevalence was estimated from self-reported data on any alcohol use during pregnancy for 2012/2013 and 2018/2019, combined with risk estimates for FASD from a meta-analysis of case-ascertainment or clinic-based studies in seven other countries. A sensitivity analysis using four more recent active case ascertainment studies was performed to account for the possibility of underestimation. RESULTS: We estimated FASD prevalence in the general population to be 1.7% (95% confidence interval [CI] 1.0%; 2.7%) in the 2012/2013 year. For Maori, the prevalence was significantly higher than for Pasifika and Asian populations. In the 2018/2019 year, FASD prevalence was 1.3% (95% CI 0.9%; 1.9%). For Maori, the prevalence was significantly higher than for Pasifika and Asian populations. The sensitivity analysis estimated the prevalence of FASD in the 2018/2019 year to range between 1.1% and 3.9% and for Maori, from 1.7% to 6.3%. DISCUSSION AND CONCLUSIONS: This study used methodology from comparative risk assessments, using the best available national data. These findings are probably underestimates but indicate a disproportionate experience of FASD by Maori compared with some ethnicities. The findings support the need for policy and prevention initiatives to support alcohol-free pregnancies to reduce lifelong disability caused by prenatal alcohol exposure.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Tardios da Exposição Pré-Natal / Transtornos do Espectro Alcoólico Fetal Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Pregnancy País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Tardios da Exposição Pré-Natal / Transtornos do Espectro Alcoólico Fetal Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Pregnancy País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article